We are live on ! Find out more
NIVF

NewGenIvf
NIVF

1 hedge funds and large institutions have $43 invested in NewGenIvf in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

93% less capital invested

Capital invested by funds: $578 → $43 (-$535)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$16
2
Morgan Stanley
Morgan Stanley
New York
-$4

NIVF Hedge Fund Activity: Q4 2025 in Review

1 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in NewGenIvf (NIVF) for Q4 2025, worth a combined $43 — down 93% from $578 a quarter earlier.

Fund positioning in NIVF was balanced in Q4 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Bank of America, cutting an estimated $16.

  • 1 institutional investor held NewGenIvf (NIVF) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $43 of NewGenIvf stock for Q4 2025, down 93% quarter-over-quarter.
  • 0 funds opened new NewGenIvf positions in Q4 2025 and 0 closed out.
  • The largest NewGenIvf seller in Q4 2025 was Bank of America, an estimated $16 sold.

Based on aggregated 13F filings for Q4 2025.